The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Interaction of Chemokine Receptor CCR5 with its Ligands: Multiple Domains for HIV-1 gp120 Binding and a Single Domain for Chemokine Binding
Open accessAbstract
CCR5 is a chemokine receptor expressed by T cells and macrophages, which also functions as the principal coreceptor for macrophage (M)-tropic strains of HIV-1. To understand the molecular basis of the binding of chemokines and HIV-1 to CCR5, we developed a number of mAbs that inhibit the various interactions of CCR5, and mapped the binding sites of these mAbs using a panel of CCR5/CCR2b chimeras. One mAb termed 2D7 completely blocked the binding and chemotaxis of the three natural chemokine ligands of CCR5, RANTES (regulated on activation normal T cell expressed and secreted), macrophage inflammatory protein (MIP)-1α, and MIP-1β, to CCR5 transfectants. This mAb was a genuine antagonist of CCR5, since it failed to stimulate an increase in intracellular calcium concentration in the CCR5 transfectants, but blocked calcium responses elicited by RANTES, MIP-1α, or MIP-1β. This mAb inhibited most of the RANTES and MIP-1α chemotactic responses of activated T cells, but not of monocytes, suggesting differential usage of chemokine receptors by these two cell types. The 2D7 binding site mapped to the second extracellular loop of CCR5, whereas a group of mAbs that failed to block chemokine binding all mapped to the NH2-terminal region of CCR5. Efficient inhibition of an M-tropic HIV-1–derived envelope glycoprotein gp120 binding to CCR5 could be achieved with mAbs recognizing either the second extracellular loop or the NH2-terminal region, although the former showed superior inhibition. Additionally, 2D7 efficiently blocked the infectivity of several M-tropic and dual-tropic HIV-1 strains in vitro. These results suggest a complicated pattern of HIV-1 gp120 binding to different regions of CCR5, but a relatively simple pattern for chemokine binding. We conclude that the second extracellular loop of CCR5 is an ideal target site for the development of inhibitors of either chemokine or HIV-1 binding to CCR5.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor
Feng, Y., Broder, C. C., Kennedy, P. E., & Berger, E. A. (1996) · Science · doi:10.1126/science.272.5263.872 · Cited by 4,172
Identification of a major co-receptor for primary isolates of HIV-1
Deng, H., Liu, R., Ellmeier, W., Choe, S., Unutmaz, D., Burkhart, M., Marzio, P. D., Marmon, S., Sutton, R. E., Hill, C. M., et al. (1996) · Nature · doi:10.1038/381661a0 · Cited by 3,641
HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5
Dragic, T., Litwin, V., Allaway, G. P., Martin, S. R., Huang, Y., Nagashima, K. A., Cayanan, C., Maddon, P. J., Koup, R. A., Moore, J. P., et al. (1996) · Nature · doi:10.1038/381667a0 · Cited by 3,174
Self-citationLiu, R., Paxton, W. A., Choe, S., Ceradini, D., Martin, S. R., Horuk, R., MacDonald, M. E., Stuhlmann, H., Koup, R. A., & Landau, N. R. (1996) · Cell · doi:10.1016/s0092-8674(00)80110-5 · Cited by 3,074
Samson, M., Libert, F., Doranz, B. J., Rucker, J., Liesnard, C., Farber, C.-M., Saragosti, S., Lapouméroulie, C., Cognaux, J., Forceille, C., et al. (1996) · Nature · doi:10.1038/382722a0 · Cited by 2,886
Self-citationCocchi, F., DeVico, A. L., Garzino-Demo, A., Arya, S. K., Gallo, R. C., & Lusso, P. (1995) · Science · doi:10.1126/science.270.5243.1811 · Cited by 2,869
CC CKR5: A RANTES, MIP-1α, MIP-1β Receptor as a Fusion Cofactor for Macrophage-Tropic HIV-1
Alkhatib, G., Combadiere, C., Broder, C. C., Feng, Y., Kennedy, P. E., Murphy, P. M., & Berger, E. A. (1996) · Science · doi:10.1126/science.272.5270.1955 · Cited by 2,706
Dean, M., Carrington, M., Winkler, C., Huttley, G. A., Smith, M. W., Allikmets, R., Goedert, J. J., Buchbinder, S. P., Vittinghoff, E., Gomperts, E., et al. (1996) · Science · doi:10.1126/science.273.5283.1856 · Cited by 2,484
The β-Chemokine Receptors CCR3 and CCR5 Facilitate Infection by Primary HIV-1 Isolates
Choe, H., Farzan, M., Sun, Y., Sullivan, N., Rollins, B., Ponath, P. D., Wu, L., Mackay, C. R., LaRosa, G., Newman, W., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81313-6 · Cited by 2,287
Self-citationInterleukin-8 and related chemotactic cytokines--CXC and CC chemokines.
Baggiolini, M., Dewald, B., & Moser, B. (1994) · PubMed · Cited by 2,226
Properties Of The Novel Proinflammatory Supergene Intercrine Cytokine Family
Oppenheim, J. (1991) · Annual Review of Immunology · doi:10.1146/annurev.immunol.9.1.617 · Cited by 1,877
Doranz, B. J., Rucker, J., Yi, Y., Smyth, R. J., Samson, M., Peiper, S. C., Parmentier, M., Collman, R. G., & Doms, R. W. (1996) · Cell · doi:10.1016/s0092-8674(00)81314-8 · Cited by 1,833
Self-citationlnterleukin-8 and Related Chemotactic Cytokines—CXC and CC Chemokines
Baggiolini, M., Dewald, B., & Moser, B. (1993) · Advances in Immunology · doi:10.1016/s0065-2776(08)60509-x · Cited by 1,671
Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES
Schall, T. J., Bacon, K., Toy, K. J., & Goeddel, D. V. (1990) · Nature · doi:10.1038/347669a0 · Cited by 1,379
The role of a mutant CCR5 allele in HIV–1 transmission and disease progression
Huang, Y., Paxton, W. A., Wolinsky, S. M., Neumann, A. U., Zhang, L., He, T., Kang, S., Ceradini, D., Jin, Z., Yazdanbakhsh, K., et al. (1996) · Nature Medicine · doi:10.1038/nm1196-1240 · Cited by 1,358
Connor, R. I., Chen, B. K., Choe, S., & Landau, N. R. (1995) · Virology · doi:10.1006/viro.1995.1016 · Cited by 1,253
The Molecular Biology of Leukocyte Chemoattractant Receptors
Murphy, P. M. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.003113 · Cited by 1,195
CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5
Wu, L., Gerard, N. P., Wyatt, R., Choe, H., Parolin, C., Ruffing, N., Borsetti, A., Cardoso, A. A., Desjardin, E., Newman, W., et al. (1996) · Nature · doi:10.1038/384179a0 · Cited by 1,167
Self-citationThe HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes
Bleul, C. C., Wu, L., Hoxie, J. A., Springer, T. A., & Mackay, C. R. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.5.1925 · Cited by 1,134
Self-citationCD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5
Trkola, A., Dragic, T., Arthos, J., Binley, J. M., Olson, W. C., Allaway, G. P., Cheng-Mayer, C., Robinson, J., Maddon, P. J., & Moore, J. P. (1996) · Nature · doi:10.1038/384184a0 · Cited by 1,034
Self-citationJose, P. J., Griffiths-Johnson, D. A., Collins, P. D., Walsh, D. T., Moqbel, R., Totty, N. F., Truong, O., Hsuan, J. J., & Williams, T. J. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.3.881 · Cited by 806
Taub, D. D., Lloyd, A. R., Conlon, K., Wang, J. M., Ortaldo, J. R., Harada, A., Matsushima, K., Kelvin, D. J., & Oppenheim, J. J. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.6.1809 · Cited by 752
Biology and biochemistry of the chemokines: a family of chemotactic and inflammatory cytokines.
Miller, M. D., & Krangel, M. S. (1992) · PubMed · Cited by 731
Ponath, P. D., Qin, S., Ringler, D. J., Clark-Lewis, I., Wang, J., Kassam, N., Smith, H., Shi, X., Gonzalo, J. A., Newman, W., et al. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118456 · Cited by 697
Self-citationCCR5 Levels and Expression Pattern Correlate with Infectability by Macrophage-tropic HIV-1, In Vitro
Wu, L., Paxton, W. A., Kassam, N., Ruffing, N., Rottman, J. B., Sullivan, N., Choe, H., Sodroski, J., Newman, W., Koup, R. A., et al. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.9.1681 · Cited by 694
Self-citationCD4-Independent Infection by HIV-2 Is Mediated by Fusin/CXCR4
Endres, M. J., Clapham, P. R., Marsh, M., Ahuja, M., Turner, J. D., McKnight, A., Thomas, J. F., Stoebenau-Haggarty, B., Choe, S., Vance, P. J., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81393-8 · Cited by 655
Paxton, W. A., Martin, S. R., Tse, D., O'Brien, T. R., Skurnick, J., VanDevanter, N. L., Padian, N., Braun, J. F., Kotler, D. P., Wolinsky, S. M., et al. (1996) · Nature Medicine · doi:10.1038/nm0496-412 · Cited by 648
Chemokines, leukocyte trafficking, and inflammation
Schall, T. J., & Bacon, K. B. (1994) · Current Opinion in Immunology · doi:10.1016/0952-7915(94)90006-x · Cited by 615
Ponath, P. D., Qin, S., Post, T. W., Wang, J., Wu, L., Gerard, N. P., Newman, W., Gerard, C., & Mackay, C. R. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.6.2437 · Cited by 612
Self-citationPotent Inhibition of HIV-1 Infectivity in Macrophages and Lymphocytes by a Novel CCR5 Antagonist
Simmons, G., Clapham, P. R., Picard, L., Offord, R. E., Rosenkilde, M. M., Schwartz, T. W., Buser, R., Wells, T. N. C., & Proudfoot, A. E. I. (1997) · Science · doi:10.1126/science.276.5310.276 · Cited by 608
Prevention of lung reperfusion injury in rabbits by a monoclonal antibody against interleukin-8
Sekido, N., Mukaida, N., Harada, A., Nakanishi, I., Watanabe, Y., & Matsushima, K. (1993) · Nature · doi:10.1038/365654a0 · Cited by 514
Heath, H., Qin, S., Rao, P., Wu, L., LaRosa, G., Kassam, N., Ponath, P. D., & Mackay, C. R. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119145 · Cited by 457
Self-citationEvidence for Cell-Surface Association Between Fusin and the CD4-gp120 Complex in Human Cell Lines
Lapham, C. K., Ouyang, J., Chandrasekhar, B., Nguyen, N. Y., Dimitrov, D. S., & Golding, H. (1996) · Science · doi:10.1126/science.274.5287.602 · Cited by 359
Ghattas, I. R., Sanes, J. R., & Majors, J. E. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.12.5848 · Cited by 349
Monocyte chemotactic protein-1 (MCP-1), -2, and -3 are chemotactic for human T lymphocytes.
Taub, D. D., Proost, P., Murphy, W. J., Anver, M., Longo, D. L., van Damme, J., & Oppenheim, J. J. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117788 · Cited by 346
Multiple Extracellular Elements of CCR5 and HIV-1 Entry: Dissociation from Response to Chemokines
Atchison, R. E., Gosling, J., Monteclaro, F. S., Franci, C., Digilio, L., Charo, I. F., & Goldsmith, M. A. (1996) · Science · doi:10.1126/science.274.5294.1924 · Cited by 308
Regions in β-Chemokine Receptors CCR5 and CCR2b That Determine HIV-1 Cofactor Specificity
Rucker, J., Samson, M., Doranz, B. J., Libert, F., Berson, J. F., Yi, Y., Smyth, R. J., Collman, R. G., Broder, C. C., Vassart, G., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81364-1 · Cited by 290
Self-citationHIV blocked by chemokine antagonist
Arenzana-Seisdedos, F., Virelizier, J.-L., Rousset, D., Clark-Lewis, I., Loetscher, P., Moser, B., & Baggiolini, M. (1996) · Nature · doi:10.1038/383400a0 · Cited by 281
Chemokine receptors and T cell chemotaxis.
Mackay, C. R. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.3.799 · Cited by 215
Self-citationHill, C. M., Deng, H., Unutmaz, D., Kewalramani, V. N., Bastiani, L., Gorny, M. K., Zolla-Pazner, S., & Littman, D. R. (1997) · Journal of Virology · doi:10.1128/jvi.71.9.6296-6304.1997 · Cited by 199
Bieniasz, P. D. (1997) · The EMBO Journal · doi:10.1093/emboj/16.10.2599 · Cited by 195
Roth, S. J., Carr, M. W., & Springer, T. A. (1995) · European Journal of Immunology · doi:10.1002/eji.1830251241 · Cited by 192
Evolution of HIV-1 coreceptor usage through interactions with distinct CCR5 and CXCR4 domains
Lu, Z.-H., Berson, J. F., Chen, Y.-H., Turner, J. D., Zhang, T.-Y., Sharron, M., Jenks, M. H., Wang, Z.-X., Kim, J., Rucker, J., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.12.6426 · Cited by 190
Inhibition of lung inflammatory reactions in rats by an anti-human IL-8 antibody
Mulligan, M. S., Jones, M. L., Bolanowski, M. A., Baganoff, M. P., Deppeler, C. L., Meyers, D. M., Ryan, U. S., & Ward, P. A. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.12.5585 · Cited by 181
Farzan, M., Choe, H., Martin, K. A., Sun, Y., Sidelko, M., Mackay, C. R., Gerard, N. P., Sodroski, J., & Gerard, C. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.11.6854 · Cited by 181
Self-citationThe Second Extracellular Loop of CCR5 Is the Major Determinant of Ligand Specificity
Samson, M., LaRosa, G., Libert, F., Paindavoine, P., Detheux, M., Vassart, G., & Parmentier, M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.40.24934 · Cited by 179
Self-citationGosling, J., Monteclaro, F. S., Atchison, R. E., Arai, H., Tsou, C.-L., Goldsmith, M. A., & Charo, I. F. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.10.5061 · Cited by 174
Qin, S., Larosa, G., Campbell, J. J., Smith‐Heath, H., Kassam, N., Shi, X., Zeng, L., Butcher, E. C., & MacKay, C. R. (1996) · European Journal of Immunology · doi:10.1002/eji.1830260320 · Cited by 167
Self-citationPerret, J., Ludgate, M., Libert, F., Gerard, C., Dumont, J. E., Gilbert, V., & Parmentier, M. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(90)90789-p · Cited by 164
Self-citationNeutralization of IL-8 inhibits neutrophil influx in a rabbit model of endotoxin-induced pleurisy.
Broaddus, V. C., Boylan, A. M., Hoeffel, J. M., Kim, K. J., Sadick, M. D., Chuntharapai, A., & Hébert, C. A. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.6.2960 · Cited by 141
The pro-inflammatory seven-transmembrane segment receptors of the leukocyte
Gerard, C. J., & Gerard, N. P. (1994) · Current Opinion in Immunology · doi:10.1016/0952-7915(94)90045-0 · Cited by 114
Discrete Steps in Binding and Signaling of Interleukin-8 with Its Receptor
Wu, L., Ruffing, N., Shi, X., Newman, W., Soler, D. F., Mackay, C. R., & Qin, S. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.49.31202 · Cited by 99
Self-citationChemokines: What chemokine is that?
Mackay, C. R. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00181-3 · Cited by 85
Self-citation
Cited by
Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease
Berger, E. A., Murphy, P. M., & Farber, J. M. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.657 · Cited by 2,180
International Union of Pharmacology. XXII. Nomenclature for Chemokine Receptors
Murphy, P. M., Baggiolini, M., Charo, I. F., Hébert, C. A., Horuk, R., Matsushima, K., Miller, L. H., Oppenheim, J. J., & Power, C. A. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01439-x · Cited by 1,817
Qin, S., Rottman, J. B., Myers, P., Kassam, N., Weinblatt, M., Loetscher, M., Koch, A. E., Moser, B., & Mackay, C. R. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1422 · Cited by 1,359
Self-citationThe Role of Chemokine Receptors in Primary, Effector, and Memory Immune Responses
Sallusto, F., Mackay, C. R., & Lanzavecchia, A. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.593 · Cited by 1,041
Self-citationAMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor
Donzella, G. A., Schols, D., Lin, S. W., Esté, J. A., Nagashima, K. A., Maddon, P. J., Allaway, G. P., Sakmar, T. P., Henson, G., DeClercq, E., et al. (1998) · Nature Medicine · doi:10.1038/nm0198-072 · Cited by 760
Self-citation
Metadata
- Authors
- Wu, L., LaRosa, G., Kassam, N., Gordon, C. J., Heath, H., Ruffing, N., Chen, H., Humblias, J., Samson, M., Parmentier, M., Moore, J. P., & Mackay, C. R.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 1997-10-20
- Volume
- 186
- Issue
- 8
- Pages
- 1373-1381
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2129875326
- Cited by
- 357
- References
- 53
- FWCI
- 15.18
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.